vTv Therapeutics
$36.56
24
-$0.74-1.98% Friday 20:00
Statistics
Day High
38.1
Day Low
35.04
52W High
44
52W Low
14
Volume
38,444
Avg. Volume
44,291
Mkt Cap
143.97M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.045
Actual EPS
N/A
Financials
-1,815.34%Profit Margin
Unprofitable2.03MRevenue
-36.92MNet Income
Analyst Ratings
$53.00Average Price Target
The highest estimate is 67.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow VTVT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap26.03B
Axsome Therapeutics
AXSM
Mkt Cap8.62B
AnaptysBio
ANAB
Mkt Cap1.66B
Acadia Pharmaceuticals
ACAD
Mkt Cap3.78B
Alkermes
ALKS
Mkt Cap5.81B
AMGEN
AMGN
Mkt Cap187.56B
Abbvie
ABBV
Mkt Cap369.39B
Lilly(Eli) &
LLY
Mkt Cap837.36B
Pfizer
PFE
Mkt Cap161.09B
About
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.
Show more...
CEO
Mr. Paul J. Sekhri
Employees
23
Country
United States
ISIN
US9183852048
Listings
0 Comments
Share your thoughts
FAQ
What is vTv Therapeutics stock price today?▼
The current price of VTVT is $36.56 USD — it has decreased by -1.98% in the past 24 hours. Watch vTv Therapeutics stock price performance more closely on the chart.
What is vTv Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange vTv Therapeutics stocks are traded under the ticker VTVT.
Is vTv Therapeutics stock price growing?▼
VTVT stock has fallen by -11.2% compared to the previous week, the month change is a +4.16% rise, over the last year vTv Therapeutics has showed a +94.78% increase.
What is vTv Therapeutics market cap?▼
Today vTv Therapeutics has the market capitalization of 143.97M
When is the next vTv Therapeutics earnings date?▼
vTv Therapeutics is going to release the next earnings report on May 07, 2026.
What were vTv Therapeutics earnings last quarter?▼
VTVT earnings for the last quarter are -0.58 USD per share, whereas the estimation was -1.09 USD resulting in a +46.69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is vTv Therapeutics revenue for the last year?▼
vTv Therapeutics revenue for the last year amounts to 2.03M USD.
What is vTv Therapeutics net income for the last year?▼
VTVT net income for the last year is -36.92M USD.
How many employees does vTv Therapeutics have?▼
As of April 11, 2026, the company has 23 employees.
In which sector is vTv Therapeutics located?▼
vTv Therapeutics operates in the Health & Wellness sector.
When did vTv Therapeutics complete a stock split?▼
The last stock split for vTv Therapeutics was on November 21, 2023 with a ratio of 1:40.
Where is vTv Therapeutics headquartered?▼
vTv Therapeutics is headquartered in High Point, United States.